Cancer care in German centers of excellence during the first 2 years of the COVID-19 pandemic

Volker Arndt; Daniela Doege; Stefan Fröhling; Peter Albers; Hana Algül; Ralf Bargou; Carsten Bokemeyer; Martin Bornhäuser; Christian H. Brandts; Peter Brossart; Sara Yvonne Brucker; Tim H. Brümmendorf; Hartmut Döhner; Norbert Gattermann; Michael Hallek; Volker Heinemann; Ulrich Keilholz; Thomas Kindler; Cornelia von Levetzow; Florian Lordick; Ulf Peter Neumann; Christoph Peters; Dirk Schadendorf; Stephan Stilgenbauer; Thomas Zander; Daniel Zips; Delia Braun; Thomas Seufferlein; Gerd Nettekoven; Michael Baumann

doi:10.1007/s00432-022-04407-1

Cancer care in German centers of excellence during the first 2 years of the COVID-19 pandemic

Volker Arndt, Daniela Doege, Stefan Fröhling, Peter Albers, Hana Algül, Ralf Bargou, Carsten Bokemeyer, Martin Bornhäuser, Christian H. Brandts, Peter Brossart, Sara Yvonne Brucker, Tim H. Brümmendorf, Hartmut Döhner, Norbert Gattermann, Michael Hallek, Volker Heinemann, Ulrich Keilholz, Thomas Kindler, Cornelia von Levetzow, Florian LordickUlf Peter Neumann, Christoph Peters, Dirk Schadendorf, Stephan Stilgenbauer, Thomas Zander, Daniel Zips, Delia Braun, Thomas Seufferlein, Gerd Nettekoven, Michael Baumann

Publikation: Beitrag in Fachzeitschrift › Brief › Begutachtung

10 Zitate (Scopus)

Abstract

Purpose: An increasing number of international studies demonstrate serious negative effects of the COVID-19 pandemic on the timely diagnosis of cancer and on cancer treatment. Our study aimed to quantitatively and qualitatively evaluate the capacities of German Comprehensive Cancer Centers (CCCs) in different areas of complex oncology care during the first 2 years of the COVID-19 pandemic. Methods: Prospective panel survey over 23 rounds among 18 CCCs in Germany between March 2020 and June 2022. Results: The COVID-19 pandemic substantially affected the oncological care system in Germany during the first 2 years. Persistent limitations of care in CCCs primarily affected follow-up (− 21%) and psycho-oncologic care (− 12%), but also tumor surgery (− 9%). Substantial limitations were also reported for all other areas of multidisciplinary oncological care. Conclusions: This study documents the limitations of oncological care during the COVID-19 pandemic and highlights the need to develop strategies to avoid similar limitations in the future.

Originalsprache	Englisch
Seiten (von - bis)	913-919
Seitenumfang	7
Fachzeitschrift	Journal of Cancer Research and Clinical Oncology
Jahrgang	149
Ausgabenummer	2
DOIs	https://doi.org/10.1007/s00432-022-04407-1
Publikationsstatus	Veröffentlicht - Feb. 2023
Extern publiziert	Ja

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

Zugriff auf Dokument

10.1007/s00432-022-04407-1

Andere Dateien und Links

Verknüpfung zur Publikation in Scopus

Dieses zitieren

Arndt, V., Doege, D., Fröhling, S., Albers, P., Algül, H., Bargou, R., Bokemeyer, C., Bornhäuser, M., Brandts, C. H., Brossart, P., Brucker, S. Y., Brümmendorf, T. H., Döhner, H., Gattermann, N., Hallek, M., Heinemann, V., Keilholz, U., Kindler, T., von Levetzow, C., ... Baumann, M. (2023). Cancer care in German centers of excellence during the first 2 years of the COVID-19 pandemic. Journal of Cancer Research and Clinical Oncology, 149(2), 913-919. https://doi.org/10.1007/s00432-022-04407-1

@article{33dc8874e08d40698078cc9c0679efbb,

title = "Cancer care in German centers of excellence during the first 2 years of the COVID-19 pandemic",

abstract = "Purpose: An increasing number of international studies demonstrate serious negative effects of the COVID-19 pandemic on the timely diagnosis of cancer and on cancer treatment. Our study aimed to quantitatively and qualitatively evaluate the capacities of German Comprehensive Cancer Centers (CCCs) in different areas of complex oncology care during the first 2 years of the COVID-19 pandemic. Methods: Prospective panel survey over 23 rounds among 18 CCCs in Germany between March 2020 and June 2022. Results: The COVID-19 pandemic substantially affected the oncological care system in Germany during the first 2 years. Persistent limitations of care in CCCs primarily affected follow-up (− 21%) and psycho-oncologic care (− 12%), but also tumor surgery (− 9%). Substantial limitations were also reported for all other areas of multidisciplinary oncological care. Conclusions: This study documents the limitations of oncological care during the COVID-19 pandemic and highlights the need to develop strategies to avoid similar limitations in the future.",

keywords = "Aftercare, Comprehensive cancer centers, Early diagnosis of cancer, SARS-CoV-2 infection, Treatment delays",

author = "Volker Arndt and Daniela Doege and Stefan Fr{\"o}hling and Peter Albers and Hana Alg{\"u}l and Ralf Bargou and Carsten Bokemeyer and Martin Bornh{\"a}user and Brandts, {Christian H.} and Peter Brossart and Brucker, {Sara Yvonne} and Br{\"u}mmendorf, {Tim H.} and Hartmut D{\"o}hner and Norbert Gattermann and Michael Hallek and Volker Heinemann and Ulrich Keilholz and Thomas Kindler and {von Levetzow}, Cornelia and Florian Lordick and Neumann, {Ulf Peter} and Christoph Peters and Dirk Schadendorf and Stephan Stilgenbauer and Thomas Zander and Daniel Zips and Delia Braun and Thomas Seufferlein and Gerd Nettekoven and Michael Baumann",

note = "Publisher Copyright: {\textcopyright} 2022, The Author(s).",

year = "2023",

month = feb,

doi = "10.1007/s00432-022-04407-1",

language = "English",

volume = "149",

pages = "913--919",

journal = "Journal of Cancer Research and Clinical Oncology",

issn = "0171-5216",

publisher = "Springer Verlag",

number = "2",

}

Arndt, V, Doege, D, Fröhling, S, Albers, P, Algül, H, Bargou, R, Bokemeyer, C, Bornhäuser, M, Brandts, CH, Brossart, P, Brucker, SY, Brümmendorf, TH, Döhner, H, Gattermann, N, Hallek, M, Heinemann, V, Keilholz, U, Kindler, T, von Levetzow, C, Lordick, F, Neumann, UP, Peters, C, Schadendorf, D, Stilgenbauer, S, Zander, T, Zips, D, Braun, D, Seufferlein, T, Nettekoven, G & Baumann, M 2023, 'Cancer care in German centers of excellence during the first 2 years of the COVID-19 pandemic', Journal of Cancer Research and Clinical Oncology, Jg. 149, Nr. 2, S. 913-919. https://doi.org/10.1007/s00432-022-04407-1

TY - JOUR

T1 - Cancer care in German centers of excellence during the first 2 years of the COVID-19 pandemic

AU - Arndt, Volker

AU - Doege, Daniela

AU - Fröhling, Stefan

AU - Albers, Peter

AU - Algül, Hana

AU - Bargou, Ralf

AU - Bokemeyer, Carsten

AU - Bornhäuser, Martin

AU - Brandts, Christian H.

AU - Brossart, Peter

AU - Brucker, Sara Yvonne

AU - Brümmendorf, Tim H.

AU - Döhner, Hartmut

AU - Gattermann, Norbert

AU - Hallek, Michael

AU - Heinemann, Volker

AU - Keilholz, Ulrich

AU - Kindler, Thomas

AU - von Levetzow, Cornelia

AU - Lordick, Florian

AU - Neumann, Ulf Peter

AU - Peters, Christoph

AU - Schadendorf, Dirk

AU - Stilgenbauer, Stephan

AU - Zander, Thomas

AU - Zips, Daniel

AU - Braun, Delia

AU - Seufferlein, Thomas

AU - Nettekoven, Gerd

AU - Baumann, Michael

PY - 2023/2

Y1 - 2023/2

N2 - Purpose: An increasing number of international studies demonstrate serious negative effects of the COVID-19 pandemic on the timely diagnosis of cancer and on cancer treatment. Our study aimed to quantitatively and qualitatively evaluate the capacities of German Comprehensive Cancer Centers (CCCs) in different areas of complex oncology care during the first 2 years of the COVID-19 pandemic. Methods: Prospective panel survey over 23 rounds among 18 CCCs in Germany between March 2020 and June 2022. Results: The COVID-19 pandemic substantially affected the oncological care system in Germany during the first 2 years. Persistent limitations of care in CCCs primarily affected follow-up (− 21%) and psycho-oncologic care (− 12%), but also tumor surgery (− 9%). Substantial limitations were also reported for all other areas of multidisciplinary oncological care. Conclusions: This study documents the limitations of oncological care during the COVID-19 pandemic and highlights the need to develop strategies to avoid similar limitations in the future.

AB - Purpose: An increasing number of international studies demonstrate serious negative effects of the COVID-19 pandemic on the timely diagnosis of cancer and on cancer treatment. Our study aimed to quantitatively and qualitatively evaluate the capacities of German Comprehensive Cancer Centers (CCCs) in different areas of complex oncology care during the first 2 years of the COVID-19 pandemic. Methods: Prospective panel survey over 23 rounds among 18 CCCs in Germany between March 2020 and June 2022. Results: The COVID-19 pandemic substantially affected the oncological care system in Germany during the first 2 years. Persistent limitations of care in CCCs primarily affected follow-up (− 21%) and psycho-oncologic care (− 12%), but also tumor surgery (− 9%). Substantial limitations were also reported for all other areas of multidisciplinary oncological care. Conclusions: This study documents the limitations of oncological care during the COVID-19 pandemic and highlights the need to develop strategies to avoid similar limitations in the future.

KW - Aftercare

KW - Comprehensive cancer centers

KW - Early diagnosis of cancer

KW - SARS-CoV-2 infection

KW - Treatment delays

UR - http://www.scopus.com/inward/record.url?scp=85140209960&partnerID=8YFLogxK

U2 - 10.1007/s00432-022-04407-1

DO - 10.1007/s00432-022-04407-1

M3 - Letter

C2 - 36241862

AN - SCOPUS:85140209960

SN - 0171-5216

VL - 149

SP - 913

EP - 919

JO - Journal of Cancer Research and Clinical Oncology

JF - Journal of Cancer Research and Clinical Oncology

IS - 2